Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Brian D. Benneyworth"'
Autor:
Elizabeth L. Eby, Alison Edwards, Eric Meadows, Ilya Lipkovich, Brian D. Benneyworth, Kenneth Snow
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background The aim of this study was to determine how clusters or subgroups of insulin-treated people with diabetes, based upon healthcare resource utilization, select social demographic and clinical characteristics, and diabetes management
Externí odkaz:
https://doaj.org/article/553ceb57866944698224fc6b6e5bcee1
Autor:
Andrew L. Beardsley MD, Mark R. Rigby MD, PhD, Terri L. Bogue MSN, RN, PCNS, Mara E. Nitu MD, Brian D. Benneyworth MD, MS
Publikováno v:
Global Pediatric Health, Vol 2 (2015)
Externí odkaz:
https://doaj.org/article/bf9cfa8de0ba4427b7e7dd781a0b4b6f
Autor:
Callahan N. Clark, Elizabeth L. Eby, Cody J. Lensing, Elena Fultz, Brian Hart, Lilian Lingcaro, Ron Hoffner, Nanette C. Schloot, Brian D. Benneyworth
Publikováno v:
Diabetes Therapy. 14:869-882
Autor:
Ágnes Benedict, Emily R. Hankosky, Kinga Marczell, Jieling Chen, David J. Klein, J. Jaime Caro, Jay P. Bae, Brian D. Benneyworth
Publikováno v:
PharmacoEconomics. 40:743-750
Autor:
Cody J. Lensing, Kristina S. Boye, Elif Tokar Erdemir, Robert J. Heine, Scott Sailer, Ramira San Juan, Abraham Reddy, Brian D. Benneyworth, Nathan D. Zimmerman, Emily R. Hankosky, Lida Etemad, Matan C. Dabora, Callahan Clark, M. Angelyn Bethel
Publikováno v:
Diabetes Therapy
Introduction Diabetes has been identified as a high-risk comorbidity for COVID-19 hospitalization. We evaluated additional risk factors for COVID-19 hospitalization and in-hospital mortality in a nationwide US database. Methods This retrospective stu
Publikováno v:
Journal of the Endocrine Society. 6:A355-A356
Tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrated clinically meaningful reductions in HbA1c and body weight that were significantly greater compared with semaglutide in patients with type 2 diabetes on background metformin. In a pre-specif
Autor:
GRAZIA ALEPPO, CHRISTOPHE DE BLOCK, JOSHUA A. LEVINE, ELISA GOMEZ-VALDERAS, BRIAN D. BENNEYWORTH
Publikováno v:
Diabetes. 71
Tirzepatide, a once weekly GIP/GLP-1 receptor agonist in development for T2D, demonstrated superior glycemic control in the Phase 3 SURPASS clinical trial program. This post-hoc analysis assessed glycemic control with tirzepatide in participants stra
Autor:
Christopher W. Mastropietro, Eric S. Ebenroth, Brian D. Benneyworth, Santosh Kaipa, Mouhammad Yabrodi
Publikováno v:
Cardiology in the Young. 31:191-198
Objective:We sought to describe patient characteristics associated with prolonged post-operative length of stay in a contemporary cohort of infants who underwent isolated repair of aortic coarctation.Methods:We reviewed patients less than 1 year of a
Publikováno v:
J Diabetes Sci Technol
Background: Does initiation of a continuous glucose monitor (CGM) or insulin pump lower health care utilization and/or costs? Methods: Distinct cohorts of people with type 1 diabetes (T1D) or type 2 diabetes (T2D) using a blood glucose monitor (BGM),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e50ec017c802df7a38c03565de0657c5
https://europepmc.org/articles/PMC10012356/
https://europepmc.org/articles/PMC10012356/
Autor:
Tellen D Bennett, Michael C Spaeder, Renee I Matos, R Scott Watson, Katri V Typpo, Robinder G Khemani, Sheri eCrow, Brian D Benneyworth, Ravi R Thiagarajan, J Michael Dean, Barry P Markovitz
Publikováno v:
Frontiers in Pediatrics, Vol 2 (2014)
Our objectives were to review and categorize the existing data sources that are important to pediatric critical care medicine (PCCM) investigators and the types of questions that have been or could be studied with each data source. We conducted a nar
Externí odkaz:
https://doaj.org/article/a89eef5fcb7c4249a84dacb35b4b01c1